TipRanks
Go Ultimate55% OFF

Hem Pharma, Inc. (376270) Stock Price & Analysis

376270 Stock Chart & Stats

₩26,200.00₩50.00(0.19%)
At close: 3:30 PM GMT+9
KRW 30,000KRW 40,0003 Aug18 Aug31 Aug14 Sep28 Sep12 Oct26 Oct
Day’s Range
KRW 25,350.00 - KRW 26,550.00
52-Week Range
KRW 25,350.00 - KRW 97,500.00
Previous Close
KRW 26,150.00
Volume
N/A
Average Volume (3M)
6,744
Market Cap
KRW 188.88B
Enterprise Value
KRW 337.72B
Total Cash (Recent Filing)
N/A
Total Debt (Recent Filing)
N/A
Price to Earnings (P/E)
―
Beta
0.32
Next Earnings
Nov 27, 2026 (Est.)
EPS Estimate
N/A
Next Dividend Ex-Date
N/A
Dividend Yield
N/A

376270 FAQ

What was Hem Pharma, Inc.’s price range in the past 12 months?
Hem Pharma, Inc. lowest stock price was ₩25350.00 and its highest was ₩97500.00 in the past 12 months.
What is Hem Pharma, Inc.’s market cap?
Hem Pharma, Inc.’s market cap is ₩188.88B.
When is Hem Pharma, Inc.’s upcoming earnings report date?
The company’s upcoming earnings report date is not yet available.
How were Hem Pharma, Inc.’s earnings last quarter?
Hem Pharma, Inc. released its earnings results on Aug 21, 2026. The company reported ₩209.242 earnings per share for the quarter.
Is Hem Pharma, Inc. overvalued?
Not enough analysts have published a price target to calculate whether the price is overvalued.
Does Hem Pharma, Inc. pay dividends?
Hem Pharma, Inc. does not currently pay dividends.
What is Hem Pharma, Inc.’s EPS estimate?
Hem Pharma, Inc.’s EPS estimate for its next earnings report is not yet available.
How many shares outstanding does Hem Pharma, Inc. have?
Hem Pharma, Inc. has 7,219,147 shares outstanding.
What happened to Hem Pharma, Inc.’s price movement after its last earnings report?
Hem Pharma, Inc. reported an EPS of ₩209.242 in its last earnings report. Following the earnings report the stock price went down -3.023%.
Which hedge fund is a major shareholder of Hem Pharma, Inc.?
Currently, no hedge funds are holding shares in KR:376270
What is the TipRanks Smart Score and how is it calculated?
Smart Score combines eight research factors - such as analyst recommendations, hedge fund trends, and technical indicators - to measure a stock’s outlook. These signals are unified into a single score that reflects bullish or bearish momentum. See detailed methodology